Medical Device Network on MSN
Olympus-backed MaxQ Medical raises $31.5M for prostate care platform’s advancement
MaxQ’s namesake platform combines advanced imaging with tissue-selective therapy in a single transurethral procedure.
Following a transurethral resection (TUR) prostatectomy for a benign enlargement, the patient complains of the lack of ejaculation and little emission, although he has a good erection. He does not ...
The article by Bryan et al entitled “Randomized Comparison of Magnetic Resonance Imaging Versus Transurethral Resection for Staging New Bladder Cancers: Results From the Prospective BladderPath Trial” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results